1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53.

MLA

Thompson, Thelma, et al. “1,25-Dihydroxyvitamin D3 Enhances the Apoptotic Activity of MDM2 Antagonist Nutlin-3a in Acute Myeloid Leukemia Cells Expressing Wild-Type P53.” Molecular Cancer Therapeutics, vol. 9, no. 5, May 2010, pp. 1158–68. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-09-1036.

APA

Thompson, T., Andreeff, M., Studzinski, G. P., & Vassilev, L. T. (2010). 1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53. Molecular Cancer Therapeutics, 9(5), 1158–1168. https://doi.org/10.1158/1535-7163.MCT-09-1036

Chicago

Thompson, Thelma, Michael Andreeff, George P Studzinski, and Lyubomir T Vassilev. 2010. “1,25-Dihydroxyvitamin D3 Enhances the Apoptotic Activity of MDM2 Antagonist Nutlin-3a in Acute Myeloid Leukemia Cells Expressing Wild-Type P53.” Molecular Cancer Therapeutics 9 (5): 1158–68. doi:10.1158/1535-7163.MCT-09-1036.